Clinical trials
Hypospadias trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
108 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 9 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 7 |
| 2018 | 7 |
| 2019 | 8 |
| 2020 | 7 |
| 2021 | 9 |
| 2022 | 5 |
| 2023 | 13 |
| 2024 | 7 |
| 2025 | 17 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 54 |
| Unknown status | 20 |
| Recruiting | 11 |
| Not yet recruiting | 8 |
| Withdrawn | 6 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 7 |
| Ain Shams University | 5 |
| Yonsei University | 4 |
| Al-Azhar University | 3 |
| Hospices Civils de Lyon | 3 |
| Mansoura University | 3 |
| Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization | 3 |
| Cairo University | 2 |
| Isfahan University of Medical Sciences | 2 |
| Johns Hopkins University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypospadias | 108 |
| Postoperative Pain | 10 |
| Cryptorchidism | 5 |
| Testicular Hydrocele | 5 |
| Disorders of Sex Development | 4 |
| Pain | 4 |
| Agnosia | 3 |
| Congenital Abnormalities | 3 |
| Fistula | 3 |
| Phimosis | 3 |
Trials
Showing 51 to 75 of 108. Each trial links to its page on Pharma Observatory.
8 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.